Sanket Dhruva
دانشیار · Medical Device and Drug Safety
University of California, San Franciscoمعرفی
Sanket Dhruva, MD, MHS is an Associate Professor in the Department of Medicine at the University of California, San Francisco (UCSF) School of Medicine. He completed his medical training at UCSF, followed by a cardiology fellowship at UC Davis, and an MHS through the Robert Wood Johnson Foundation Clinical Scholars Program at Yale University. Dr. Dhruva's work focuses on medical device and drug safety, regulation, and evidence generation, with particular expertise in cardiovascular devices and Medicare coverage policies.
Education
- BA in Molecular & Cell Biology and Political Science from UC Berkeley (2005)
- MD from UCSF School of Medicine (2009)
- Internal Medicine Residency at UCSF Department of Medicine (2012)
- Cardiology Fellowship at UC Davis Division of Cardiovascular Medicine (2015)
- MHS through Robert Wood Johnson Foundation Clinical Scholars Program at Yale University (2017)
- LEAN Champion training at UCSF (2019)
- Diversity, Equity, and Inclusion Champion Training at UCSF (2021)
Research Interests
Dr. Dhruva's research spans several interconnected areas centered around medical device and drug safety, regulation, and evidence generation. His work examines FDA approval processes for high-risk medical devices, Medicare coverage determinations, and the generation of real-world evidence to inform clinical practice and policy decisions.
A significant portion of his research focuses on cardiovascular devices, including pacemakers, implantable cardioverter-defibrillators, and transcatheter valve technologies. He investigates safety concerns, appropriate utilization, and regulatory pathways for these devices. His work often involves large dataset analyses to evaluate device performance in real-world settings.
Dr. Dhruva also studies Medicare formulary coverage policies, particularly how coverage decisions are made for novel drugs and devices, and the implications for patient access and healthcare costs. His research on the Medicare Coverage with Evidence Development program has been particularly influential in understanding how evidence generation requirements impact coverage decisions.
Publication Trends
Dr. Dhruva's recent publications (2023-2025) demonstrate a continued focus on medical device regulation, safety, and evidence generation. His work spans multiple high-impact journals including JAMA, New England Journal of Medicine, and Journal of the American College of Cardiology. A notable trend is increased attention to remote monitoring of cardiovascular implantable electronic devices, artificial intelligence applications in cardiology, and the implications of Medicare payment policies for medical technologies.
His research shows growing interest in health equity considerations for medical device development and use, as evidenced by recent publications on challenges and solutions for advancing health equity with medical devices. There's also a clear pattern of examining how regulatory decisions impact clinical practice, with particular attention to the FDA's Breakthrough Devices Program and Unique Device Identifier implementation.
Professional Activities
Dr. Dhruva maintains active collaborations with the Veterans Health Administration on research related to cardiovascular device monitoring. His work often involves multi-institutional teams spanning UCSF, Yale, and other academic medical centers. He serves as a reviewer for major medical journals and contributes to policy discussions regarding medical device regulation and evidence generation.
